Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07822113) titled 'A Multicenter Randomized Cross-Over Study Evaluating the Efficacy and Safety of Silodosin in Adult Women With Voiding Dysfunction' on Sept. 10.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Jaber Al Ahmad Al Sabah Hospital
Condition:
Voiding Dysfunction
Female LUTS
Intervention:
Drug: Silodosin 8 mg
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: October 2026
Target Sample Size: 150
Countr...